Lars Johansson

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 855 citations · Full text

Thrombosis, Cardiovascular Disease, Stroke +13

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 749 citations · Full text

Thrombosis, Cardiovascular Disease, Atherosclerosis +12

Ankle brachial index <0.9 underestimates the prevalence of peripheral artery occlusive disease assessed with whole-body magnetic resonance angiography in the elderly

Johan Wikström, Thorsten Hansen, Lars Johansson et al. · Acta Radiologica · 2008 · 58 citations

Synthesis of Novel 5-Substituted 3-Amino-3,4-dihydro-2<i>H</i>-1-benzopyran Derivatives and Their Interactions with the 5-HT_1A Receptor

Eva Hammarberg, Gunnar Nordvall, Robert Leideborg et al. · Journal of Medicinal Chemistry · 2000 · 21 citations · Full text

Combinatorial Chemistry, Bioorganic Chemistry, Organic Chemistry +16

Kinetic Studies of Acetate Exchange in<i>trans</i>-4-Acetoxy-[<i>η</i>³-(1,2,3)-cyclohexenyl]palladium Complexes. Relevance for Asymmetric 1,4-Oxidation Reactions

Hanna K. Cotton, Renzo C. Verboom, Lars Johansson et al. · Organometallics · 2002 · 11 citations